Brief: J&J-backed Startup Rapport Aims Up To $636.8 Mln Valuation In US IPO

Rapport Therapeutics

03/06/2024 11:20

June 3 (Reuters) - 
    Rapport Therapeutics:
  
    * RAPPORT THERAPEUTICS INC SAYS CURRENTLY ESTIMATED IPO
PRICE WILL
BE BETWEEN $16.00 AND $18.00 PER SHARE - SEC FILING
    * RAPPORT THERAPEUTICS INC SEES IPO OF UP TO 8 MILLION
SHARES OF
COMMON STOCK

Source text for Eikon:  ID:n0001193125-24-152294 

 ((Reuters.Briefs@thomsonreuters.com;))